<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35830514</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0987</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>The Pediatric infectious disease journal</Title><ISOAbbreviation>Pediatr Infect Dis J</ISOAbbreviation></Journal><ArticleTitle>Etiology and Risk Factors for Admission to the Pediatric Intensive Care Unit in Children With Encephalitis in a Developing Country.</ArticleTitle><Pagination><StartPage>806</StartPage><EndPage>812</EndPage><MedlinePgn>806-812</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/INF.0000000000003637</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To describe a cohort of pediatric patients with encephalitis and their risk factors for admission to the pediatric intensive care unit (PICU).</AbstractText><AbstractText Label="STUDY DESIGN">Children (&lt;18 years old), with encephalitis evaluated by conventional microbiology and syndromic, multiplex test in cerebrospinal fluid (CSF) between July 2017 and July 2020, were recruited from 14 hospitals that comprise the Colombian Network of Encephalitis in Pediatrics. Multivariate analyses were used to evaluate risk factors associated with the need for PICU admission.</AbstractText><AbstractText Label="RESULTS">Two hundred two children were included, of which 134 (66.3%) were male. The median age was 23 months (IQR 5.7-73.2). The main etiologies were bacteria (n = 55, 27%), unspecified viral encephalitis (n = 44, 22%) and enteroviruses (n = 27, 13%), with variations according to age group. Seventy-eight patients (38.6%) required management in the PICU. In multivariate analysis, factors associated with admission to the PICU were the presence of generalized seizures (OR 2.73; 95% CI: 1.82-4.11), status epilepticus (OR 3.28; 95% CI: 2.32-4.62) and low leukocyte counts in the CSF (OR 2.86; 95% CI: 1.47-5.57). Compared with enterovirus, bacterial etiology (OR 7.50; 95% CI: 1.0-56.72), herpes simplex encephalitis (OR 11.81; 95% CI: 1.44-96.64), autoimmune encephalitis (OR 22.55; 95% CI: 3.68-138.16) and other viral infections (OR 5.83; 95% CI: 1.09-31.20) increased the risk of PICU admission.</AbstractText><AbstractText Label="CONCLUSIONS">Data from this national collaborative network of pediatric patients with encephalitis allow early identification of children at risk of needing advanced care and can guide the risk stratification of admission to the PICU.</AbstractText><CopyrightInformation>Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guerrero</LastName><ForeName>María P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>From the Department of Pediatrics, Universidad del Valle, Cali, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romero</LastName><ForeName>Andrés F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Hospital Universitario de Neiva, Huila, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Universidad Surcolombiana, Neiva, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luengas</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Infectious Diseases Unit, Fundación Hospital Pediátrico la Misericordia, Bogotá, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Hospital Militar Central, Bogotá, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dávalos</LastName><ForeName>Diana M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Centro de Estudios en Infectología Pediátrica, Cali, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health, Universidad Icesi, Cali, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mesa-Monsalve</LastName><ForeName>Juan Gonzalo</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Clínica Las Américas Auna, Medellín, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vivas-Trochez</LastName><ForeName>Rosalba</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Clínica SOMA, Universidad Cooperativa de Colombia, Medellín, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camacho-Moreno</LastName><ForeName>German</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Infectious Diseases Unit, Fundación Hospital Pediátrico la Misericordia, Bogotá, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad Nacional de Colombia, Bogotá, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trujillo-Valencia</LastName><ForeName>Mónica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Hospital Pablo Tobón Uribe, Medellín, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad CES, Medellín, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad Pontificia Bolivariana, Medellín, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giraldo</LastName><ForeName>Juan P Calle</ForeName><Initials>JPC</Initials><AffiliationInfo><Affiliation>Centro de Estudios en Infectología Pediátrica, Cali, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Universidad del Quindío, Armenia, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mejía</LastName><ForeName>Luis F</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Fundación Clínica Infantil Club Noel, Cali, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas-Hernández</LastName><ForeName>Juan P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>From the Department of Pediatrics, Universidad del Valle, Cali, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Fundación Clínica Infantil Club Noel, Cali, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad Libre, Cali, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vinasco</LastName><ForeName>Nathaly</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Universidad Libre, Cali, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Racines</LastName><ForeName>Andrea Ruiz</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Universidad Libre, Cali, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meléndez</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Universidad Libre, Cali, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beltrán</LastName><ForeName>Claudia P</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Universidad de Antioquia, Clínica el Rosario, Clínica del Prado, Medellín, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>López</LastName><ForeName>Pio</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-5230-6595</Identifier><AffiliationInfo><Affiliation>From the Department of Pediatrics, Universidad del Valle, Cali, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Estudios en Infectología Pediátrica, Cali, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaucanez</LastName><ForeName>Yamile</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Hospital Infantil Los Ángeles, Pasto, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patiño</LastName><ForeName>Jaime</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Fundación Valle del Lili, Cali, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodríguez</LastName><ForeName>Wilfrido Coronell</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Hospital Infantil Napoleón Franco Pareja, Universidad de Cartagena, Cartagena, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salgado</LastName><ForeName>Doris</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Hospital Universitario de Neiva, Huila, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martínez</LastName><ForeName>Marly</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Hospital Universitario de Neiva, Huila, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Restrepo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Infectious Diseases Unit, Fundación Hospital Pediátrico la Misericordia, Bogotá, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad Nacional de Colombia, Bogotá, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Márquez</LastName><ForeName>Kelly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Infectious Diseases Unit, Fundación Hospital Pediátrico la Misericordia, Bogotá, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad Nacional de Colombia, Bogotá, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galvis</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Infectious Diseases Unit, Fundación Hospital Pediátrico la Misericordia, Bogotá, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benavidez</LastName><ForeName>Iván</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>From the Department of Pediatrics, Universidad del Valle, Cali, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas</LastName><ForeName>Christian A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>From the Department of Pediatrics, Universidad del Valle, Cali, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cantor</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centro de Estudios en Infectología Pediátrica, Cali, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad de Valparaíso, Valparaíso, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>López Medina</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-3066-5938</Identifier><AffiliationInfo><Affiliation>From the Department of Pediatrics, Universidad del Valle, Cali, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Estudios en Infectología Pediátrica, Cali, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clínica Imbanaco, Grupo Quirón Salud, Cali, Colombia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Infect Dis J</MedlineTA><NlmUniqueID>8701858</NlmUniqueID><ISSNLinking>0891-3668</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003906" MajorTopicYN="Y">Developing Countries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004660" MajorTopicYN="Y">Encephalitis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015278" MajorTopicYN="N">Intensive Care Units, Pediatric</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no funding or conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>13</Day><Hour>14</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35830514</ArticleId><ArticleId IdType="doi">10.1097/INF.0000000000003637</ArticleId><ArticleId IdType="pii">00006454-202210000-00004</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rismanchi N, Gold JJ, Sattar S, et al. Neurological outcomes after presumed childhood encephalitis. Pediatr Neurol. 2015;53:200–206.</Citation></Reference><Reference><Citation>Erickson TA, Muscal E, Munoz FM, et al. Infectious and autoimmune causes of encephalitis in children. Pediatrics. 2020;145:e20192543.</Citation></Reference><Reference><Citation>Posnakoglou L, Siahanidou T, Syriopoulou V, et al. Impact of cerebrospinal fluid syndromic testing in the management of children with suspected central nervous system infection. Eur J Clin Microbiol Infect Dis. 2020;39:2379–2386.</Citation></Reference><Reference><Citation>George BP, Schneider EB, Venkatesan A. Encephalitis hospitalization rates and inpatient mortality in the United States, 2000-2010. PLoS One. 2014;9:e104169.</Citation></Reference><Reference><Citation>Bagdure D, Custer JW, Rao S, et al. Hospitalized children with encephalitis in the United States: A Pediatric Health Information System Database Study. Pediatr Neurol. 2016;61:58–62.</Citation></Reference><Reference><Citation>Messacar K, Fischer M, Dominguez SR, et al. Encephalitis in US children. Infect Dis Clin North Am. 2018;32:145–162.</Citation></Reference><Reference><Citation>Precit MR, Yee R, Pandey U, et al. Cerebrospinal fluid findings are poor predictors of appropriate filmarray meningitis/encephalitis panel utilization in pediatric patients. J Clin Microbiol. 2020;58:e01592–e01519.</Citation></Reference><Reference><Citation>Fowler Å, Ygberg S, Svensson E, et al. Prospective evaluation of childhood encephalitis: predisposing factors, prevention and outcome. Pediatr Infect Dis J. 2020;39:e417–e422.</Citation></Reference><Reference><Citation>Kestenbaum LA, Ebberson J, Zorc JJ, et al. Defining cerebrospinal fluid white blood cell count reference values in neonates and young infants. Pediatrics. 2010;125:257–264.</Citation></Reference><Reference><Citation>Venkatesan A, Tunkel AR, Bloch KC, et al.; International Encephalitis Consortium. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis. 2013;57:1114–1128.</Citation></Reference><Reference><Citation>Hanson KE, Slechta ES, Killpack JA, et al. Preclinical assessment of a fully automated multiplex PCR panel for detection of central nervous system pathogens. J Clin Microbiol. 2016;54:785787.</Citation></Reference><Reference><Citation>Leber AL, Everhart K, Balada-Llasat JM, et al. Multicenter evaluation of biofire filmarray meningitis/encephalitis panel for detection of bacteria, viruses, and yeast in cerebrospinal fluid specimens. J Clin Microbiol. 2016;54:2251–2261.</Citation></Reference><Reference><Citation>Glaser CA, Honarmand S, Anderson LJ, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis. 2006;43:1565–1577.</Citation></Reference><Reference><Citation>Bloch KC, Glaser CA. Encephalitis Surveillance through the Emerging Infections Program, 1997-2010. Emerg Infect Dis. 2015;21:15621567.</Citation></Reference><Reference><Citation>Glaser CA, Gilliam S, Schnurr D, et al. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. Clin Infect Dis. 2003;36:731742.</Citation></Reference><Reference><Citation>Cizman M, Jazbec J. Etiology of acute encephalitis in childhood in Slovenia. Pediatr Infect Dis J. 1993;12:903–908.</Citation></Reference><Reference><Citation>Britton PN, Dale RC, Blyth CC, et al. Causes and clinical features of childhood encephalitis: A Multicenter, Prospective Cohort Study. Clin Infect Dis. 2020;70:2517–2526.</Citation></Reference><Reference><Citation>Yao K, Honarmand S, Espinosa A, et al. Detection of human herpesvirus-6 in cerebrospinal fluid of patients with encephalitis. Ann Neurol. 2009;65:257–267.</Citation></Reference><Reference><Citation>Green DA, Pereira M, Miko B, et al. Clinical significance of human herpesvirus 6 positivity on the filmarray meningitis/encephalitis panel. Clin Infect Dis. 2018;67:1125–1128.</Citation></Reference><Reference><Citation>Lindström J, Elfving K, Lindh M, et al. Assessment of the FilmArray ME panel in 4199 consecutively tested cerebrospinal fluid samples. Clin Microbiol Infect. 2022;28:79–84.</Citation></Reference><Reference><Citation>de Crom SC, Rossen JW, van Furth AM, et al. Enterovirus and parechovirus infection in children: a brief overview. Eur J Pediatr. 2016;175:1023–1029.</Citation></Reference><Reference><Citation>Messacar K, Breazeale G, Wei Q, et al. Epidemiology and clinical characteristics of infants with human parechovirus or human herpes virus-6 detected in cerebrospinal fluid tested for enterovirus or herpes simplex virus. J Med Virol. 2015;87:829–835.</Citation></Reference><Reference><Citation>Lieke B, Betrian MRE, Dasja P, et al. World-wide prevalence and genotype distribution of Parechovirus A. Virol Retrovirol J. 2019;2:115.</Citation></Reference><Reference><Citation>Davies EA, Turner A. The utility of cerebro spinal fluid white cell count and lymphocite differential in predicting viral meningitis and encephalitis. In: The Congress of ESCMID. M-anage.com; 2019.</Citation></Reference><Reference><Citation>Gable MS, Sheriff H, Dalmau J, et al. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis. 2012;54:899–904.</Citation></Reference><Reference><Citation>Gable M, Glaser C. Anti-N-Methyl-d-aspartate receptor encephalitis appearing as a new-onset psychosis: disease course in children and adolescents within the california encephalitis project. Pediatr Neurol. 2017;72:25–30.</Citation></Reference><Reference><Citation>LaRovere KL, Riggs BJ, Poussaint TY, et al.; Overcoming COVID-19 Investigators. Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome. JAMA Neurol. 2021;78:536–547.</Citation></Reference><Reference><Citation>Lin WL, Chi H, Huang FY, et al. Analysis of clinical outcomes in pediatric bacterial meningitis focusing on patients without cerebrospinal fluid pleocytosis. J Microbiol Immunol Infect. 2016;49:723–728.</Citation></Reference><Reference><Citation>Erdem H, Ozturk-Engin D, Cag Y, et al.; ID-IRI study group. Central nervous system infections in the absence of cerebrospinal fluid pleocytosis. Int J Infect Dis. 2017;65:107–109.</Citation></Reference><Reference><Citation>Petel D, Barton M, Renaud C, et al. Enteroviral and herpes simplex virus central nervous system infections in infants &lt;90 days old: a Paediatric Investigators’ Collaborative Network on Infections in Canada (PICNIC) study. BMC Pediatr. 2020;20:252.</Citation></Reference><Reference><Citation>Patone M, Thomas K, Hatch R, et al. Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study. Lancet Infect Dis. 2021;21:1518–1528.</Citation></Reference><Reference><Citation>D’Onofrio V, Meersman A, Vijgen S, et al. Risk factors for mortality, intensive care unit admission, and bacteremia in patients suspected of sepsis at the emergency department: A Prospective Cohort Study. Open Forum Infect Dis. 2021;8:ofaa594.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>